R&D Super-Deduction Tax Incentive

R&D Super-Deduction Tax Incentive

Provides Chinese companies a tax deduction framework for qualifying innovation spend through annual tax filing.

China's R&D Super-Deduction (研发费用加计扣除) is a nationwide corporate income tax incentive that allows qualifying PRC-registered enterprises to deduct eligible research and development expenditures at 200% of actual spend when computing taxable income. This policy rate was confirmed post-2023, particularly for manufacturing sector companies, and represents an effective cash-equivalent benefit of up to 18% of qualifying R&D spend for enterprises paying the standard 25% corporate income tax (CIT) rate. For companies holding Hi-Tech Enterprise (HTE) certification and taxed at the preferential 15% CIT rate, the combined benefit can reach 30% of eligible R&D expenditure.

The deduction is claimed through the annual corporate income tax return filed with the State Taxation Administration (STA) and its local tax bureaus; no competitive application process exists and no advance pre-approval is required. Eligible expenditures include staff costs for R&D personnel, direct materials consumed in R&D activities, equipment depreciation attributable to R&D, and outsourced R&D fees. Companies must maintain qualifying R&D project documentation and cost-allocation records to substantiate the deduction upon audit. Hi-Tech Enterprise certification, issued jointly by the Ministry of Science and Technology (MOST) and provincial Science and Technology bureaus, unlocks the preferential 15% CIT rate as a separate complementary benefit.

All PRC-registered for-profit enterprises engaging in qualifying R&D activity are eligible, with no sector restrictions at the national policy level. Service and trading companies may apply a lower enhanced-deduction ratio (historically 175%) compared to manufacturing companies, though post-2023 policy announcements have moved toward the unified 200% rate for most sectors. Companies operating in China through Wholly Foreign-Owned Enterprises (WFOEs) or Sino-foreign joint ventures are eligible on the same basis as domestic firms, provided R&D activity occurs within China and meets the qualifying criteria under the implementation rules issued by the STA.